Levity First-Month vs Refill Pricing: What Long-Term Treatment Costs

Last reviewed: September 18, 2026 Last updated: September 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Levity advertises a first-month introductory rate of $1,149 for Ozempic, $1,249 for Mounjaro, and $1,549 for Wegovy when you apply a sign-up discount (verified September 4, 2026 at joinlevity.com). Starting with your second shipment the price rises to $1,199, $1,299, or $1,599 per four-week cycle—no membership fee, medication and visits included. If you stay on treatment for twelve months the effective monthly average lands at $1,195 for Ozempic, $1,295 for Mounjaro, and $1,595 for Wegovy (our calculation). Compounded semaglutide and tirzepatide, which are not FDA-approved and not interchangeable with branded drugs, run $189 and $289 per month respectively at PlexusDx with no first-month discount and no price increase at refill.

At-a-glance: Levity's first-month vs refill pricing

Pricing verified September 4, 2026 at joinlevity.com. All figures are per four-week cycle. Levity bills every ~4 weeks and includes medication, provider consult, care coordination, and shipping with no separate membership fee. The sign-up discount is publicly advertised; we did not capture terms limiting its use. Twelve-month totals are our calculation: first-month rate plus eleven refills.

Why the first-month discount matters less than you think

The sign-up discount saves you $50 in cycle one—a 4.2 percent discount on Ozempic, 3.8 percent on Mounjaro, 3.1 percent on Wegovy. If you refill even once the promotional savings shrink to 2.1, 1.9, and 1.6 percent respectively over two cycles (our calculation). By month six the first-month discount represents less than one percent of your cumulative spend, and by month twelve it rounds to zero in any practical budget conversation. The number that governs your annual cost is the $1,199–$1,599 you pay every four weeks starting in cycle two, not the advertised sign-up figure.

Levity's billing cadence runs every four weeks rather than calendar monthly, which means you will be charged thirteen times in a fifty-two-week year. For budget modeling we use twelve cycles—roughly the same duration as one calendar year—to keep comparisons legible, but be aware that your actual annual spend will include one additional refill.

Twelve-month cost breakdown: what you actually pay

Here is the simple arithmetic for each Levity option, assuming you use the sign-up discount and continue treatment without interruption:

Ozempic (branded semaglutide)

• Month 1: $1,149 (first-month introductory rate with sign-up discount, verified September 4, 2026)
• Months 2–12: $1,199 × 11 = $13,189
• 12-month total: $14,338 (our calculation)
• Effective monthly average: $1,195

Mounjaro (branded tirzepatide)

• Month 1: $1,249 (first-month introductory rate with sign-up discount, verified September 4, 2026)
• Months 2–12: $1,299 × 11 = $14,289
• 12-month total: $15,538 (our calculation)
• Effective monthly average: $1,295

Wegovy (branded semaglutide)

• Month 1: $1,549 (first-month introductory rate with sign-up discount, verified September 4, 2026)
• Months 2–12: $1,599 × 11 = $17,589
• 12-month total: $19,138 (our calculation)
• Effective monthly average: $1,595

All three options bill you every four weeks and include medication, clinician visits, ongoing care coordination, and shipping in the posted price. Levity does not charge a separate membership fee (verified September 4, 2026). You can cancel anytime according to the site's terms, though we did not verify whether partial-cycle refunds are available.

Branded vs compounded GLP-1: the regulatory and cost divide

Levity dispenses FDA-approved branded medications—Ozempic and Mounjaro (approved for type 2 diabetes and sometimes prescribed off-label for weight management) and Wegovy (approved specifically for chronic weight management). These drugs have passed Phase III trials, carry FDA-reviewed labeling, and are manufactured under current Good Manufacturing Practice rules in facilities inspected by the agency.

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

The cost difference between these two regulatory pathways is large. PlexusDx charges $189 per month for compounded semaglutide injection and $289 per month for compounded tirzepatide injection, both on a month-to-month basis with no first-month discount, no refill increase, and no membership fee (pricing verified July 17–23, 2026). Over twelve months that produces a total cost of $2,268 for semaglutide and $3,468 for tirzepatide (our calculation)—a difference of $12,070 and $12,070 respectively when compared to Levity's Ozempic and Mounjaro twelve-month totals.

Levity monthly averages and twelve-month totals are our calculation. PlexusDx pricing is month-to-month; lower per-month rates are available on three-month ($169 semaglutide, $269 tirzepatide) and six-month ($149 semaglutide, $249 tirzepatide) plans, further widening the cost gap.

Compounded medications are not interchangeable with their branded counterparts, and they carry different supply-chain and regulatory oversight. The price difference reflects both the absence of brand-name markup and the different manufacturing and approval pathways.

What Levity includes at every price point

Levity's pricing is all-inclusive regardless of which medication you choose. Every four-week cycle covers:

• The branded medication itself (Ozempic, Mounjaro, or Wegovy)
• Initial provider consultation to determine eligibility and write the prescription
• Ongoing care coordination and clinician messaging
• Shipping to your address

There is no separate membership fee, lab-test charge, or visit copay on top of the posted cycle price (verified September 4, 2026). If you need to change your dose or switch medications the provider visit to authorize that change is included, though switching to a different drug—say, from Ozempic to Mounjaro—will move you to that drug's pricing tier starting with your next shipment.

When branded drugs justify the premium

Three scenarios favor paying Levity's rates for FDA-approved medications:

1. Your insurance covers a meaningful share. Some employer and exchange plans now include GLP-1 agonists on formulary with prior authorization, and a few cover them for weight management rather than diabetes alone. If your plan pays 50 percent or more of Levity's posted price, your out-of-pocket cost drops into a range where the branded-vs-compounded decision becomes less clear-cut. Confirm both the drug-specific formulary tier and whether the plan reimburses telehealth prescriptions before assuming coverage.

2. You want the drug that carried the weight-management indication in its pivotal trial. Wegovy and Ozempic both contain semaglutide, but Wegovy's FDA approval is based on trials enrolling patients without diabetes who were treated specifically for weight management. If that distinction matters to you—for instance, because you want the dose escalation and maintenance schedule that matched the trial protocol—Levity offers direct access without prior-authorization delays.

3. Regulatory certainty outweighs cost in your decision calculus. Branded medications carry FDA-approved labeling, batch-to-batch consistency requirements, and post-market surveillance obligations that compounded drugs do not. If you place high personal weight on those features the premium may be justified, particularly if you are budgeting for only a few months of treatment rather than a full year.

Outside those three scenarios the cost arithmetic is difficult to ignore. Paying an additional $12,000 per year for the branded version of the same active ingredient represents a roughly 530 percent markup over compounded semaglutide and a roughly 350 percent markup over compounded tirzepatide (our calculation, comparing Levity Ozempic and Mounjaro to PlexusDx month-to-month rates).

Choose Levity if…

• Your insurance covers a substantial portion of the $1,199–$1,599 per cycle cost and you have confirmed the plan reimburses telehealth GLP-1 prescriptions.
• You specifically want Wegovy because its approval pathway and trial population match your clinical profile.
• You are comfortable with the four-week billing cycle and have budgeted for thirteen charges per fifty-two-week year.
• You prefer branded medications and are willing to pay the associated premium for FDA-reviewed manufacturing and labeling.

Choose PlexusDx if…

• You are paying out of pocket and long-term cost is a primary factor in your decision.
• You want pricing transparency with no first-month discount that obscures the true recurring cost.
• You are comfortable with compounded medications and understand they are not FDA-approved and not interchangeable with branded drugs.
• You value the option to lock in a lower per-month rate with a three-month ($169 semaglutide, $269 tirzepatide) or six-month ($149 semaglutide, $249 tirzepatide) commitment, further reducing annual cost.
• You want the same flat rate at every dose, avoiding mid-treatment price increases as you titrate upward.

Limitations and what we could not verify

Levity's website states "cancel anytime," but we did not locate terms describing partial-cycle refunds, pause options, or notice periods (search conducted September 4, 2026). If you stop treatment mid-cycle confirm whether you receive a prorated refund or credit toward a future shipment.

We captured pricing and inclusions but did not verify eligibility criteria, BMI thresholds, contraindication screening protocols, or state-specific licensing restrictions. Approval is not automatic; a provider must review your intake and determine that a prescription is appropriate.

Levity's site also lists compounded liraglutide as available, but we did not capture pricing, first-month terms, or refill structure for that option (verified September 4, 2026). If you are considering liraglutide request a written quote before starting intake.

Methodology and freshness

Levity pricing, billing cadence, inclusions, and sign-up discount details were verified September 4, 2026 by visiting joinlevity.com and reviewing the publicly accessible pricing page and FAQ. We applied the sign-up discount in the site's cost calculator to confirm the first-month rate and observed the refill prices displayed for months two and beyond.

PlexusDx pricing was verified July 17–23, 2026 from live product pages at plexusdx.com. PlexusDx's Trustpilot rating (4.3 stars, 79 percent five-star, 83 percent four-star or higher) was captured September 9, 2026 from trustpilot.com/review/plexusdx.com.

All twelve-month totals, effective monthly averages, cost differences, and percentage comparisons in this article are our calculation. We used twelve four-week cycles as the modeling period for legibility, though in practice a fifty-two-week year would produce thirteen billing events. We assume uninterrupted treatment and no mid-year price changes; confirm current rates at checkout.

Frequently Asked Questions

Does Levity charge the first-month price again when you refill?

No. The first-month rate of $1,149 (Ozempic), $1,249 (Mounjaro), or $1,549 (Wegovy) applies only to your initial shipment when you use the sign-up discount. Starting with your second four-week cycle the price rises to $1,199, $1,299, or $1,599 respectively and remains at that level for all subsequent refills, verified September 4, 2026 at joinlevity.com.

Are Levity's medications FDA-approved?

Yes. Levity dispenses branded FDA-approved drugs: Ozempic and Mounjaro (approved for type 2 diabetes, sometimes prescribed off-label for weight management) and Wegovy (approved for chronic weight management). These are distinct from compounded medications, which are not FDA-approved and do not undergo pre-market review for safety, effectiveness, or quality.

How much do you actually spend in a year with Levity?

If you use the sign-up discount and stay on treatment for twelve four-week cycles, you will spend $14,338 on Ozempic, $15,538 on Mounjaro, or $19,138 on Wegovy (our calculation). Because Levity bills every four weeks rather than calendar monthly, a fifty-two-week year includes thirteen billing events, adding one additional cycle to the annual total.

Can you pause or cancel Levity without penalty?

Levity states "cancel anytime" on its website (verified September 4, 2026), but we did not locate terms specifying partial-cycle refunds, required notice periods, or pause options. If you need to stop treatment mid-cycle, contact Levity directly to confirm whether you receive a prorated refund or account credit before your next scheduled billing date.

Is compounded semaglutide interchangeable with Ozempic or Wegovy?

No. Compounded medications are not FDA-approved, not reviewed by FDA for safety or effectiveness before marketing, and not interchangeable with branded drugs. A licensed clinician determines whether a compounded prescription is appropriate. PlexusDx works with licensed 503A compounding pharmacies. The active ingredient is semaglutide in both cases, but manufacturing pathway, regulatory oversight, and supply-chain requirements differ.

Sources

• Levity pricing, billing terms, inclusions, and sign-up discount verified September 4, 2026 at joinlevity.com
• PlexusDx pricing verified July 17–23, 2026 at plexusdx.com product pages
• PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher) captured September 9, 2026 from trustpilot.com/review/plexusdx.com
• Twelve-month cost calculations, effective monthly averages, and cost-difference figures are our calculation based on verified pricing as of the capture dates above

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.